WBA241227C9000
- 0.64
- -0.03-4.48%
Walgreens Boots Alliance Newsroom
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Walgreens Boots Alliance (WBA) and Bicycle Therapeutics (BCYC)
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Morgan Stanley Sticks to Its Sell Rating for Walgreens Boots Alliance (WBA)
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Announces Target Price $14
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Walgreens Boots Alliance (WBA)
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating
Raymond James Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Maintains Target Price $14
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $14
TD Cowen Remains a Buy on Walgreens Boots Alliance (WBA)
Walgreens Boots Alliance: Sell Rating Amidst Uncertainty and Financial Strain
Hold Rating on Walgreens Boots Alliance Amid Acquisition Talks and Valuation Pressures
RBC Capital Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Cuts Target Price to $9
Walgreens Boots Alliance Is Maintained at Sector Perform by RBC Capital
Walgreens Boots Alliance Analyst Ratings
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $8 From $10, Maintains In Line Rating
HSBC Adjusts Walgreens Boots Alliance's Price Target to $7.60 From $7, Keeps Reduce Rating
Truist Financial Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Announces Target Price $10
Walgreens Boots Alliance Analyst Ratings
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Maintains Target Price $14